The Role of Systemic Chemotherapy

34.

Helm CW, Randall-Whitis L, Martin RS et al (2007) Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma. Gynecol Oncol 105:90–96CrossRefPubMed

35.

Cotte E, Glehen O, Mohamed F et al (2007) Cytoreductive surgery and intraperitoneal chemohyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients. World J Surg. 31:1813–1820CrossRefPubMed

36.

Ansaloni L, Agnoletti V, Amadori A et al (2012) Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer. J Gynecol Cancer 22:778–785CrossRef

37.

Roviello F, Marrelli D, de Manzoni G et al (2003) Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 90:1113–1119CrossRefPubMed

38.

Sugarbaker PH, Yonemura Y (2000) Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: Best palliation with a ray of hope of cure. Oncology 58:96–107CrossRefPubMed

39.

Hultman B, Lind P, Glimelius B et al (2013) Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy. Acta Oncol 52:824–830CrossRefPubMed

40.

Costa WL, Coimbra FJ, Ribeiro FS et al (2012) Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients. World J Surg Oncol 10:195CrossRefPubMedCentralPubMed

41.

Müller H, Hotopp TH, Tofeili A, Wutke K Systemic chemotherapy using FLOT – regimen combined with cytoreductive surgery plus hipec for treatment of peritoneal metastasized gastric cancer. http://www.onkochirurgie.de/content/public/local/systemic_chemotherapy_using_flot.html

42.

Yonemura Y, Elnemr A, Endou Y et al (2012) Effects of neoadjuvant intraperitoneal/systemic chemotherapy (bidirectional chemotherapy) for the treatment of patients with peritoneal metastasis from gastric cancer. Int J Surg Oncol 2012:148420PubMedCentralPubMed

43.

Yonemura Y, Elnemr A, Endou Y et al (2010) Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol 2:85–97CrossRefPubMedCentralPubMed

44.

Yu W, Whang I, Chung HY et al (2001) Indications for earl postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J Surg 25:985–990CrossRefPubMed

45.

Yan TD, Black D, Sugarbaker PH et al (2007) A systematic review and metaanalysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 14:2702–2713CrossRefPubMed

Only gold members can continue reading. Log In or Register to continue